{{Rsnum
|rsid=10519410
|Chromosome=4
|position=137213427
|Orientation=minus
|GMAF=0.1951
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 28.3 | 69.9
| HCB | 2.2 | 36.5 | 61.3
| JPT | 3.5 | 30.1 | 66.4
| YRI | 8.8 | 35.4 | 55.8
| ASW | 5.3 | 24.6 | 70.2
| CHB | 2.2 | 36.5 | 61.3
| CHD | 6.4 | 37.6 | 56.0
| GIH | 9.9 | 45.5 | 44.6
| LWK | 6.4 | 25.5 | 68.2
| MEX | 3.4 | 24.1 | 72.4
| MKK | 8.4 | 41.6 | 50.0
| TSI | 7.8 | 29.4 | 62.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23719583
  |Trait=Adverse response to radiation therapy
  |Title=Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.
  |RiskAllele=
  |Pval=1E-6
  |OR=1.50
  |ORtxt=[1.0-2.3]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}